|
|
Volumn 36, Issue 12, 2013, Pages
|
|
Cromolyn sodium for insulin-induced lipoatrophy: Old drug, new use
a,b
c
a
a,b
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CROMOGLYCATE DISODIUM;
HUMAN INSULIN;
INSULIN;
INSULIN ASPART;
INSULIN DETEMIR;
INSULIN GLARGINE;
INSULIN LISPRO;
ISOPHANE INSULIN;
ANTIASTHMATIC AGENT;
ANTIDIABETIC AGENT;
INSULIN DERIVATIVE;
ABSENCE OF SIDE EFFECTS;
ADOLESCENT;
AUTOIMMUNE DISEASE;
CHILD;
CLINICAL ARTICLE;
CONTINUOUS INFUSION;
CONTROLLED STUDY;
DRUG EFFICACY;
DRUG INDICATION;
DRUG RESPONSE;
DRUG TOLERABILITY;
FEMALE;
HASHIMOTO DISEASE;
HUMAN;
HYPERTHYROIDISM;
INJECTION SITE;
INSULIN DEPENDENT DIABETES MELLITUS;
LETTER;
LIPOATROPHY;
MALE;
PRESCHOOL CHILD;
RETROSPECTIVE STUDY;
SCHOOL CHILD;
TREATMENT DURATION;
CHEMICALLY INDUCED;
DIABETES MELLITUS, TYPE 1;
FOLLOW UP;
LIPODYSTROPHY;
SUBCUTANEOUS DRUG ADMINISTRATION;
YOUNG ADULT;
ADOLESCENT;
ANTI-ASTHMATIC AGENTS;
CROMOLYN SODIUM;
DIABETES MELLITUS, TYPE 1;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
HYPOGLYCEMIC AGENTS;
INJECTIONS, SUBCUTANEOUS;
INSULINS;
LIPODYSTROPHY;
MALE;
YOUNG ADULT;
|
|
EID: 84891872252
PISSN: 01495992
EISSN: 19355548
Source Type: Journal
DOI: 10.2337/dc13-1123 Document Type: Letter |
|
Times cited : (16)
|
|
References (4)
|
